Alexza Pharmaceuticals Inc.
DelistedCIK 1344413fmd_1W03MX7JTEW1ZMT0JJ8C8HX1C9Manufacturing · Pharmaceutical PreparationsTemplate: Standard
Coverage: Jan 01, 2001 to Mar 31, 2016, 33 periods
Latest annual · FY2015
Millions- Total revenues
- 5
- Gross profit
- (16)
- Operating income
- (40)
- Net income
- (21)
- Free cash flow
- (32)
Latest quarter · Q1 FY2016
Millions- Total revenues
- 1
- Gross profit
- (0)
- Operating income
- (5)
- Net income
- (3)
- Free cash flow
- (4)
Key stats
Open AnalysisCompound annual growth
- Revenue, 3 yearsFY2012 to FY2015
- +7.3%
- Revenue, 5 yearsFY2010 to FY2015
- -34.9%
- Net income, 5 yearsFY2010 to FY2015
- n/m
Alexza Pharmaceuticals Inc. financials: quick answers
Annual figures as filed with the SEC. Each number links to the filing it came from and to its proof.
| Metric | FY2015 | FY2014 | Change | Source |
|---|---|---|---|---|
| Revenue | $5 million | $5.6 million | -9.6% | 10-K 2016-03-28 · proof |
| Gross profit | -$16.1 million | -$10.4 million | 10-K 2016-03-28 · proof | |
| Operating income | -$40 million | -$37.5 million | 10-K 2016-03-28 · proof | |
| Net income | -$21.3 million | -$36.7 million | 10-K 2016-03-28 · proof | |
| Cash from operating activities | -$31.9 million | -$41.5 million | 10-K 2016-03-28 · proof | |
| Free cash flow | -$31.9 million | -$43.9 million | 10-K 2016-03-28 · proof | |
| Total assets | $14.7 million | $61.6 million | -76.1% | 10-K 2016-03-28 · proof |
| Total liabilities | $86.4 million | $113.2 million | -23.7% | 10-K 2016-03-28 · proof |
| Cash and cash equivalents | $7.8 million | $15.2 million | -49% | 10-K 2016-03-28 · proof |
- What was Alexza Pharmaceuticals Inc.'s revenue in fiscal 2015?
- Alexza Pharmaceuticals Inc. reported revenue of $5 million for fiscal 2015 (the year ended Dec 31, 2015), against $5.6 million the year before (-9.6%). Source: the 10-K filed with the SEC on Mar 28, 2016. SEC
- What was Alexza Pharmaceuticals Inc.'s gross profit in fiscal 2015?
- Alexza Pharmaceuticals Inc. reported gross profit of -$16.1 million for fiscal 2015 (the year ended Dec 31, 2015), against -$10.4 million the year before. Source: the 10-K filed with the SEC on Mar 28, 2016. SEC
- What was Alexza Pharmaceuticals Inc.'s operating income in fiscal 2015?
- Alexza Pharmaceuticals Inc. reported operating income of -$40 million for fiscal 2015 (the year ended Dec 31, 2015), against -$37.5 million the year before. Source: the 10-K filed with the SEC on Mar 28, 2016. SEC
- What was Alexza Pharmaceuticals Inc.'s net income in fiscal 2015?
- Alexza Pharmaceuticals Inc. reported net income of -$21.3 million for fiscal 2015 (the year ended Dec 31, 2015), against -$36.7 million the year before. Source: the 10-K filed with the SEC on Mar 28, 2016. SEC
- What was Alexza Pharmaceuticals Inc.'s cash from operating activities in fiscal 2015?
- Alexza Pharmaceuticals Inc. reported cash from operating activities of -$31.9 million for fiscal 2015 (the year ended Dec 31, 2015), against -$41.5 million the year before. Source: the 10-K filed with the SEC on Mar 28, 2016. SEC
- What was Alexza Pharmaceuticals Inc.'s free cash flow in fiscal 2015?
- Alexza Pharmaceuticals Inc. reported free cash flow of -$31.9 million for fiscal 2015 (the year ended Dec 31, 2015), against -$43.9 million the year before. Source: the 10-K filed with the SEC on Mar 28, 2016. SEC
- What are Alexza Pharmaceuticals Inc.'s total assets?
- As of Dec 31, 2015, Alexza Pharmaceuticals Inc. reported total assets of $14.7 million, against $61.6 million a year earlier (-76.1%). Source: the 10-K filed with the SEC on Mar 28, 2016. SEC
- What are Alexza Pharmaceuticals Inc.'s total liabilities?
- As of Dec 31, 2015, Alexza Pharmaceuticals Inc. reported total liabilities of $86.4 million, against $113.2 million a year earlier (-23.7%). Source: the 10-K filed with the SEC on Mar 28, 2016. SEC
- What are Alexza Pharmaceuticals Inc.'s cash and cash equivalents?
- As of Dec 31, 2015, Alexza Pharmaceuticals Inc. reported cash and cash equivalents of $7.8 million, against $15.2 million a year earlier (-49%). Source: the 10-K filed with the SEC on Mar 28, 2016. SEC
Read from the FinancialMD API on Nov 14, 2026. Values change only when a new filing is made; see the Financials tab for every period and as-of replay.
The same numbers for an agent, with proof on every value:
curl "https://api.financial.md/v1/company/financials/income_statement/standardized?company=cik:1344413&period_type=annual&limit=5"Information only, not investment advice.